NLS Pharmaceutics AG (NLSP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.94
-0.09 (-4.43%)
At close: Jan 15, 2025, 3:59 PM
1.98
2.06%
After-hours Jan 15, 2025, 06:15 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 897.68K | 8.95M | 5.43M | 93.71K | 220.27K | 6.68K | 2.18M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | 67.95K | 54.47K | 55.47K | n/a |
Other Long-Term Assets | 16.89K | 12.14K | 12.04K | 946.91K | 260.21K | 1.00 | 14.37K |
Receivables | 10.66K | n/a | n/a | n/a | 75.39K | 36.89K | n/a |
Inventory | n/a | -41.24K | -38.55K | -61.21K | n/a | -9.36K | n/a |
Other Current Assets | 914.72K | 191.02K | 215.87K | 14.41K | 15.07K | 46.59K | 2.63K |
Total Current Assets | 1.82M | 9.25M | 5.72M | 196.71K | 381.75K | 90.16K | 2.27M |
Property-Plant & Equipment | 6.69K | 18.10K | 29.51K | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 23.58K | 30.25K | 41.55K | 1.01M | 314.68K | 55.47K | 14.37K |
Total Assets | 1.85M | 9.28M | 5.76M | 1.21M | 696.43K | 145.63K | 2.29M |
Account Payables | 4.63M | 2.37M | 1.74M | 4.01M | 2.51M | 1.13M | 564.95K |
Deferred Revenue | n/a | n/a | 2.50B | 2.50B | -1 | n/a | n/a |
Short-Term Debt | 1.63M | n/a | n/a | 1.77M | 690.07K | 707.68K | n/a |
Other Current Liabilities | 1.65M | 986.44K | 666.45K | 1.43M | 835.68K | 576.31K | 425.00K |
Total Current Liabilities | 7.92M | 3.36M | 2.40M | 7.20M | 4.04M | 2.41M | 989.96K |
Long-Term Debt | n/a | n/a | n/a | 313.48K | 152.06K | 6.39M | 8.87M |
Other Long-Term Liabilities | 260.69K | 136.12K | 318.89K | 178.27K | 180.25K | 159.02K | 148.25K |
Total Long-Term Liabilities | 2.76M | 2.64M | 2.82M | 2.99M | 2.83M | 6.54M | 9.02M |
Total Liabilities | 10.68M | 6.00M | 5.22M | 10.20M | 6.87M | 8.96M | 10.01M |
Total Debt | 1.63M | n/a | n/a | 2.08M | 842.13K | 7.09M | 8.87M |
Common Stock | 733.41K | 668.55K | 344.44K | 145.14K | 145.14K | 133.54K | 128.34K |
Retained Earnings | -70.37M | -58.20M | -41.71M | -29.76M | -26.90M | -21.45M | -16.30M |
Comprehensive Income | -158.07K | -50.79K | -151.74K | -19.38K | -18.70K | -11.25K | -9.99K |
Shareholders Equity | -8.83M | 3.28M | 542.39K | -8.98M | -6.17M | -8.81M | -7.72M |
Total Investments | n/a | n/a | n/a | 67.95K | 54.47K | 55.47K | n/a |